Viewing Study NCT00005951

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:44 PM
Ignite Modification Date: 2026-04-04 @ 3:49 AM
Study NCT ID: NCT00005951
Status: COMPLETED
Last Update Posted: 2014-08-22
First Post: 2000-07-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma
Sponsor: Duke University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult brain tumor View
None adult glioblastoma View
None adult anaplastic astrocytoma View
None adult anaplastic oligodendroglioma View
None adult mixed glioma View
None adult giant cell glioblastoma View
None adult gliosarcoma View